文献速递临床试验与 GCP医学人工智能与信息学新药、器械与细胞基因治疗研发

以用户为中心的临床决策支持在急诊科实施丁丙诺啡治疗阿片类物质使用障碍:EMBED实用性集群随机对照试验

User centered clinical decision support to implement initiation of buprenorphine for opioid use disorder in the emergency department: EMBED pragmatic cluster randomized controlled trial.
PubMed 文献 · BMJ · 2022-06-27

EMBED实用性集群随机对照试验在5个州18个急诊科集群、599名主治医师和5047名成人阿片类物质使用障碍患者中,评估以用户为中心的临床决策支持工具与常规诊疗对急诊丁丙诺啡启动率的影响。结果显示干预组患者层面启动率为12.5%,常规诊疗组为12.0%,调整后OR为1.22(95%CI 0.61至2.43,P=0.58),无显著差异;但干预组至少启动一次丁丙诺啡的医师比例为44.4%,常规诊疗组为34.0%(OR 1.83,95%CI 1.16至2.89,P=0.01)。

要点

  • 以用户为中心的临床决策支持未提高患者层面急诊丁丙诺啡启动率。
  • 干预组患者启动率为12.5%,常规诊疗组为12.0%,调整后OR 1.22(95%CI 0.61至2.43,P=0.58)。
  • 干预组至少启动一次丁丙诺啡的医师比例为44.4%,常规诊疗组为34.0%(OR 1.83,95%CI 1.16至2.89,P=0.01)。

核心结论

  • 以用户为中心的临床决策支持未增加急诊科阿片类物质使用障碍患者层面丁丙诺啡的启动率。
  • 尽管简化和自动化电子健康记录工作流程可能提高复杂、不熟悉的循证实践的采纳,仍需更多干预措施来关注成瘾治疗的其他障碍,并提高急诊科阿片类物质使用障碍患者丁丙诺啡的启动率。

研究设计与样本

  • 实用性集群随机对照试验(EMBED),比较以用户为中心的临床决策支持工具与常规诊疗。
  • 设置:美国东北部、东南部和西部5个州5个医疗系统的18个急诊科集群,涵盖社区医院至三级医疗中心,使用Epic或Cerner电子健康记录平台。
  • 参与者:599名主治急诊医师照护的5047名成人阿片类物质使用障碍患者。
  • 干预:以用户为中心、面向医师的临床决策支持系统,无缝整合入电子健康记录用户工作流程,帮助临床医师诊断阿片类物质使用障碍、评估戒断严重程度、激励患者接受治疗,并通过自动化临床和就诊后文档、医嘱录入、处方和转诊完成电子健康记录任务。
  • 主要结局指标:急诊科阿片类物质使用障碍患者中丁丙诺啡启动率(给予或处方丁丙诺啡)。

主要发现

  • 2019年11月至2021年5月评估了1 413 693次急诊就诊(干预组775 873次,常规诊疗组637 820次),最终纳入5047名阿片类物质使用障碍患者(干预组2787名,常规诊疗组2260名),由599名主治医师(干预组340名,常规诊疗组259名)照护进行分析。
  • 干预组347名(12.5%)患者启动丁丙诺啡,常规诊疗组271名(12.0%)患者启动丁丙诺啡(调整广义估计方程OR 1.22,95%CI 0.61至2.43,P=0.58)。
  • 干预组151名(44.4%)医师至少启动一次丁丙诺啡,常规诊疗组88名(34.0%)医师至少启动一次丁丙诺啡(OR 1.83,95%CI 1.16至2.89,P=0.01)。

关键数值与推荐

  • 患者层面丁丙诺啡启动率:干预组12.5% vs 常规诊疗组12.0%,调整OR 1.22(95%CI 0.61至2.43,P=0.58)。
  • 医师层面至少启动一次丁丙诺啡比例:干预组44.4% vs 常规诊疗组34.0%,OR 1.83(95%CI 1.16至2.89,P=0.01)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the effect of a user centered clinical decision support tool versus usual care on rates of initiation of buprenorphine in the routine emergency care of individuals with opioid use disorder. DESIGN: Pragmatic cluster randomized controlled trial (EMBED). SETTING: 18 emergency department clusters across five healthcare systems in five states representing the north east, south east, and western regions of the US, ranging from community hospitals to tertiary care centers, using either the Epic or Cerner electronic health record platform. PARTICIPANTS: 599 attending emergency physicians caring for 5047 adult patients presenting with opioid use disorder. INTERVENTION: A user centered, physician facing clinical decision support system seamlessly integrated into user workflows in the electronic health record to support initiating buprenorphine in the emergency department by helping clinicians to diagnose opioid use disorder, assess the severity of withdrawal, motivate patients to accept treatment, and complete electronic health record tasks by automating clinical and after visit documentation, order entry, prescribing, and referral. MAIN OUTCOME MEASURES: Rate of initiation of buprenorphine (administration or prescription of buprenorphine) in the emergency department among patients with opioid use disorder. Secondary implementation outcomes were measured with the RE-AIM (reach, effectiveness, adoption, implementation, and maintenance) framework. RESULTS: 1 413 693 visits to the emergency department (775 873 in the intervention arm and 637 820 in the usual care arm) from November 2019 to May 2021 were assessed for eligibility, resulting in 5047 patients with opioid use disorder (2787 intervention arm, 2260 usual care arm) under the care of 599 attending physicians (340 intervention arm, 259 usual care arm) for analysis. Buprenorphine was initiated in 347 (12.5%) patients in the intervention arm and in 271 (12.0%) patients in the usual care arm (adjusted generalized estimating equations odds ratio 1.22, 95% confidence interval 0.61 to 2.43, P=0.58). Buprenorphine was initiated at least once by 151 (44.4%) physicians in the intervention arm and by 88 (34.0%) in the usual care arm (1.83, 1.16 to 2.89, P=0.01). CONCLUSIONS: User centered clinical decision support did not increase patient level rates of initiating buprenorphine in the emergency department. Although streamlining and automating electronic health record workflows can potentially increase adoption of complex, unfamiliar evidence based practices, more interventions are needed to look at other barriers to the treatment of addiction and increase the rate of initiating buprenorphine in the emergency department in patients with opioid use disorder. TRIAL REGISTRATION: ClinicalTrials.gov NCT03658642.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Melnick ER, Nath B, Dziura JD, et al. User centered clinical decision support to implement initiation of buprenorphine for opioid use disorder in the emergency department: EMBED pragmatic cluster randomized controlled trial. BMJ. 2022. PMID: 35760423. doi:10.1136/bmj-2021-069271

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。